Health & Fitness

Medical emergencies need to be handled without any difficulties, as they can lead to deterioration of health for the patients, risking their lives to a great extent. FALC Emergency is dedicated to organizing ICU Train Ambulance Service in Guwahati that lets patients have a non-risky traveling experience with end-to-end comfort maintained inside the train compartments so that the journey turns out to be favorable as per their requirements. We managed to complete the process of evacuation without risking the lives of the patients on the way. Our main focus is to deliver to patients the atmosphere of an intensive care unit on the train inside the pre-booked AC compartments that are transformed to resemble a hospital-like environment. We transfer the patient based on their needs, transporting them in AC 1st, 2nd, or 3rd Class coaches to convert them into an ICU set up, installing all the necessary equipment like ventilator, cardiac monitor, infusion pump, suction pumps, and oxygen ... Continue reading →

According to FutureWise analysis the market for Cardiac Resynchronization Therapy in 2023 is US$ 4.48 billion, and is expected to reach US$ 6.68 billion by 2031 at a CAGR of 5.10%. The market for Cardiac Resynchronization Therapy Devices (CRT-D) is expected to lead in dominance throughout the forecast period. A study published in the Journal of Cardiovascular Electrophysiology indicates that more than half of the implants for CRT products utilize CRT-D devices. Significant growth is anticipated in the Latin America and Asia Pacific regions, which are expected to contribute over 25% of total revenue. This growth is driven by the rapid industrial development of key market players in distribution and manufacturing sectors. Additionally, the ongoing need for optimized operational efficiency and competitive pricing is likely to enable companies to enhance their market presence in emerging economies such as Mexico and India. In countries like Japan, the increasing adoption of quadripolar ... Continue reading →

According to FutureWise analysis the market for cath lab in 2023 is US$ 48.59 billion, and is expected to reach US$ 75.24 billion by 2031 at a CAGR of 5.60%. A catheterization lab, commonly referred to as a cath lab, is a specialized medical facility equipped with diagnostic imaging technology that allows for the visual examination of the heart's arteries and chambers. Most catheterization labs operate as "single-plane" facilities, featuring one X-ray generator and an X-ray image intensifier for fluoroscopic imaging. Historically, older cath labs recorded information on cine films, while modern labs have transitioned to digital technology. Modern digital cardiac catheterization laboratories employ advanced flat panel detectors and typically function as biplane systems featuring dual X-ray sources. The staffing structure of cardiac catheterization laboratories generally consists of multidisciplinary teams comprised of various healthcare professionals. This team typically ... Continue reading →

According to FutureWise analysis the market for cath lab in 2023 is US$ 48.59 billion, and is expected to reach US$ 75.24 billion by 2031 at a CAGR of 5.60%. A catheterization lab, commonly referred to as a cath lab, is a specialized medical facility equipped with diagnostic imaging technology that allows for the visual examination of the heart's arteries and chambers. Most catheterization labs operate as "single-plane" facilities, featuring one X-ray generator and an X-ray image intensifier for fluoroscopic imaging. Historically, older cath labs recorded information on cine films, while modern labs have transitioned to digital technology. Modern digital cardiac catheterization laboratories employ advanced flat panel detectors and typically function as biplane systems featuring dual X-ray sources. The staffing structure of cardiac catheterization laboratories generally consists of multidisciplinary teams comprised of various healthcare professionals. This team typically ... Continue reading →

According to FutureWise analysis the market for Carfilzomib in 2023 wasUS$ 0.2 billion, and is expected to reach US$ 0.25 billion by 2031 at a CAGR of 2.80%. Carfilzomib (also known as Kyprolis) is an anti-cancer medication that is derived from epoxomicin. This is a naturally occurring compound. Carfilzomib is a drug that binds to the 20-S proteasome. It also inhibits chymotrypsin activity. Injections of Carfilzomib are combined with drugs like lenalidomide or dexamethasone to treat blood cancer and multiple myeloma. The drug is very viable but it has few side effects. These include severe bloating, blood in the urine, and chest pain. Carfilzomib can also be divided based on type and strength. A 10mg injection is the most potent and a 60mg injection is the strongest. Carfilzomib has many advantages over traditional cancer treatment therapies, including increased efficacy and fewer side effects. Carfilzomib, a new proteasome inhibitor, exhibits high selectivity for the N-terminal and ... Continue reading →

According to FutureWise analysis the market for Caspofungin in 2023 is US$ 0.51 billion, and is expected to reach US$ 0.61 billion by 2031 at a CAGR of 2.20%. Caspofungin is a lipopeptide antifungal medication that specifically targets the enzyme known as β-D-glucan synthase, which plays a crucial role in maintaining the integrity of the fungal cell wall. This drug is part of a novel class of antifungals known as Echinocandins and has been approved by the FDA for clinical use. It is administered intravenously. The market for caspofungin is projected to undergo substantial growth due to a variety of factors. There has been a notable increase in the incidence of invasive candidiasis, correlating with an uptick in the utilization of echinocandins. Furthermore, enhancements in purchasing power and disposable income in developing countries, coupled with heightened awareness regarding the preventive measures against various microbial infections, are anticipated to bolster market demand. ... Continue reading →

According to FutureWise analysis the market for Carfilzomib in 2023 is US$ 0.2 billion, and is expected to reach US$ 0.25 billion by 2031 at a CAGR of 2.80% Carfilzomib, marketed under the trade name Kyprolis, is an anti-cancer medication derived from the naturally occurring compound epoxomicin. It is notable for its ability to bind to the 20-S proteasome and inhibit chymotrypsin activity, making it an effective treatment for blood cancers, particularly multiple myeloma. Carfilzomib is typically administered in combination with other medications such as lenalidomide or dexamethasone to enhance its therapeutic effects. One of the significant advantages of Carfilzomib is its increased efficacy compared to traditional cancer therapies, along with a relatively favorable side effect profile. However, some patients may experience side effects such as severe bloating, blood in the urine, chest pain, nausea, diarrhea, muscle pain, and headaches. While most side effects can alleviate within a ... Continue reading →

Understanding Pituitary Tumors and Their Impact A pituitary tumor is a mass in the pituitary gland located at the bottom of the brain, which is the main organ for hormone production. The tumors are mostly non-cancerous; however, if they are not managed properly, they could affect the hormone systems and health indirectly in a great way. The tumor is the source of a big disturbance of the hormone production that is necessary for body functions such as metabolism, reproductive health, and the stress response. In such instances, the symptoms that appear might be very slight and can be confused with other diseases, thus resulting in late diagnosis and treatment. Individuals in Kolkata can rest assured that the presence of specialists and healthcare centres dedicated to the cause will guarantee access to timely and effective intervention for conditions such as a Pituitary Brain tumor Kolkata. This is because the condition is being recognized as a treatable health issue with the ... Continue reading →

According to FutureWise analysis, the market for Brachytherapy in 2023 is US$0.96 billion, and is expected to reach US$1.7 billion by 2031 at a CAGR of 7.30%. The global brachytherapy market is poised for substantial growth over the next decade, with forecasts indicating compound annual growth rates (CAGR) ranging from approximately 5.9% to 9.0%. This promising expansion is expected to significantly increase market valuations, starting from an estimated USD 1.24 to 1.33 billion in the mid-2020s, and projected to reach between USD 2.5 and 2.94 billion by the mid-2030s. Several factors are driving this growth trajectory. Firstly, the rising prevalence of cancer worldwide is placing increasing demand on efficient and effective treatment options. Brachytherapy, which involves placing radioactive sources near or within tumors, offers a targeted approach that minimizes damage to surrounding healthy tissues, making it a preferred choice for many oncologists. Additionally, ongoing ... Continue reading →

According to FutureWise analysis, the market for brain computer interface in 2023 is US$2 billion, and is expected to reach US$7.38 billion by 2031 at a CAGR of 17.70%. The global Brain-Computer Interface (BCI) market is poised for significant growth, with projections indicating a substantial increase from approximately USD 2.62 billion in 2024 to an impressive USD 12.4 billion by 2034. This substantial growth represents a robust compound annual growth rate (CAGR) of around 17.3% to 17.4% throughout the forecast period. Various analyses highlight that the market may reach approximately USD 6.5 billion by 2030 or even USD 8.7 billion by 2033. This anticipated growth showcases a dynamic momentum fueled by ongoing technological advancements and the broadening scope of applications across several key sectors, including healthcare—where BCIs promise new avenues for patient rehabilitation—communication, which could transform interaction for those with mobility challenges, and ... Continue reading →